ONWARD Medical

ONWARD Medical is a clinical-stage medical device company developing non-invasive spinal cord stimulation therapies for people with spinal cord injury (SCI). The company's primary commercial product is the ARCEX System, a transcutaneous electrical spinal cord stimulation device FDA-cleared and CE-marked for improving hand sensation and strength in individuals with chronic cervical spinal cord injury (C2-C8). The ARCEX System comprises a wearable stimulator that delivers programmed electrical pulses via electrodes placed on the skin at the back of the neck, designed for use in conjunction with functional task practice in clinical rehabilitation settings and home-based exercise programs. The company has received 10 FDA Breakthrough Device Designations and holds nearly 400 issued or pending patents. Clinical evidence from the Up-LIFT study, published in Nature Medicine, demonstrated that 90% of 65 participants improved upper limb strength or function, with 87% reporting improved quality of life. ONWARD is also developing investigational therapies including ARCIM (implantable spinal cord stimulation) and ARCBCI (brain-computer interface combined systems), neither yet commercially available. The company collaborates with leading SCI research centers and rehabilitation organizations globally. Manufacturing and clinical delivery capabilities support both clinic-based and at-home patient use.